Retatrutide Vial | 40mg

Retatrutide Vial | 40mg

£100.00
Sale price  £100.00 Regular price 
Skip to product information
Retatrutide Vial | 40mg
GLP-1 | GIP | Glucagon

Retatrutide Vial | 40mg

40mg Retatrutide research solution, precisely dosed and independently verified by Janoshik Analytical. Triple GLP antagonist, studied extensively in published clinical trial settings. For research purposes only.
£100.00

Unlock an instant 10% off

Enter your email to get an instant 10% off your order

Your discount code
VIAL10
Apply this code at checkout to get your discount

Meet The Retatrutide Vial

  • Lyophilised research vial format
  • ≥99% purity, third-party verified
  • Custom synthesised formulation
  • Free shipping on all UK orders

Retatrutide | A synthetic triple hormone receptor agonist targeting GIP, GLP-1 and glucagon receptors simultaneously. Studied extensively in controlled clinical trial settings for its role in metabolic regulation and adipose tissue research models.*


Our compounds are manufactured by Homopeptides and every batch is independently analysed by Janoshik Analytical before reaching you. Janoshik are one of the most respected third-party testing laboratories in the peptide research space — their verification gives you confidence in every order.

Download Certificate of Analysis

This compound is supplied as a lyophilized (freeze-dried) powder for laboratory research. Store in a cool, dry environment and keep protected from direct light, heat and moisture. For longer-term storage, refrigeration is recommended. Avoid repeated temperature fluctuations and keep the vial securely sealed until required for research. Do not use if the product shows unexpected discolouration, moisture ingress or other signs of deterioration. Stability may vary depending on storage conditions and handling. For laboratory and research purposes only. Not for human consumption.

All orders are dispatched within 1–2 business days. Compounds are packaged with temperature-controlled materials to maintain integrity during transit. Free shipping on all UK orders.

the no1.
retatrutide holds the record for the highest body weight reduction ever observed for a weight loss compound in published clinical trial history*
Browse catalogue

*Based on published clinical trial data. Jastreboff AM et al. 'Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.' N Engl J Med. 2023. TRIUMPH Phase 3 program, Eli Lilly, 2024. For research purposes only. Not for human use.

Compounds built for
precision

29%
Body weight reduction recorded in Phase 3 TRIUMPH-4 trial results over 68 weeks.
100%
Of participants on retatrutide lost at least 5% body weight by week 48.
*Based on published peer-reviewed in-vitro research. For research purposes only. *Jastreboff AM et al. 'Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial.' N Engl J Med. 2023. TRIUMPH Phase 3 program, Eli Lilly, 2024. Individual results not implied or guaranteed.

Premium research peptides

  • Synthesised to ≥99% purity — independently verified by third-party labs
  • Full Certificate of Analysis included with every order
  • Dispatched within 24 hours — discreet packaging as standard
Browse catalogue